Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH trial)

被引：0
|
作者：
Coyle, V. [1 ]
Forde, C. [1 ]
Adams, R. [2 ]
Barnes, R. [3 ]
Chau, I. [4 ]
Clarke, M. [5 ]
Doran, A. [6 ]
Grayson, M. [7 ]
McAuley, D. [8 ]
McDowell, C. [6 ]
Phair, G.
Plummer, R. [9 ]
Thomas, A. [10 ]
Wilson, R. [11 ]
McMullan, R. [8 ]
机构：
[1] Queens Univ, Patrick G Johnston Ctr Canc Res, Belfast, Antrim, North Ireland
[2] Velindre Canc Ctr, Oncol, Cardiff, Wales
[3] Cardiff Univ, Sch Med, Cardiff, Wales
[4] Royal Marsden NHS Fdn Trust, Med, Sutton, Surrey, England
[5] Queens Univ, Northern Ireland Methodol Hub, Belfast, Antrim, North Ireland
[6] Belfast HSC Trust, Northern Ireland Clin Trials Unit, Belfast, Antrim, North Ireland
[7] Belfast HSC Trust, Northern Ireland Canc Res Consumer Forum, Belfast, Antrim, North Ireland
[8] Queens Univ, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland
[9] Freeman Rd Hosp, NHS Fdn Trust, Northern Ctr Canc Care, Sir Bobby Robson Canc Trials Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England
[10] Univ Leicester, Leicester Canc Res Ctr, Leicester, Leics, England
[11] Beatson Canc Ctr, Med Oncol, Glasgow, Lanark, Scotland
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1676
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1704P
引用
收藏
页码：S1188 / S1188
页数：1
相关论文
共 50 条
  • [21] Early Oral Antibiotic Switch Compared with Conventional Intravenous Antibiotic Therapy for Acute Cholangitis with Bacteremia
    Tae Young Park
    Jung Sik Choi
    Tae Jun Song
    Jae Hyuk Do
    Seong-Ho Choi
    Hyoung-Chul Oh
    Digestive Diseases and Sciences, 2014, 59 : 2790 - 2796
  • [22] Early Oral Antibiotic Switch Compared with Conventional Intravenous Antibiotic Therapy for Acute Cholangitis with Bacteremia
    Park, Tae Young
    Choi, Jung Sik
    Song, Tae Jun
    Do, Jae Hyuk
    Choi, Seong-Ho
    Oh, Hyoung-Chul
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (11) : 2790 - 2796
  • [23] Early discharge and ambulatory care of low-risk patients with neutropenic fever in Australia
    Hocking, C.
    Taylor, A.
    Hayward, A.
    INTERNAL MEDICINE JOURNAL, 2013, 43 (05) : 591 - 595
  • [24] Oral switch vs. continued intravenous antibiotic therapy in patients with bacteraemia and sepsis: a systematic review and meta-analysis
    Li, Qinyuan
    Zhou, Qi
    Fan, Jiangbo
    Huang, Siyuan
    Chen, Yaolong
    Song, Fujian
    Fu, Zhou
    Liu, Enmei
    Tang, Daolin
    Zeng, Ling
    Luo, Zhengxiu
    CLINICAL MICROBIOLOGY AND INFECTION, 2025, 31 (04) : 551 - 559
  • [25] EARLY DISCHARGE AND ORAL ANTIBIOTIC THERAPY IN LOW-RISK PATIENTS WITH FEBRILE NEUTROPENIA: THE EXPERIENCE FROM GOLD COAST UNIVERSITY HOSPITAL
    Dzienis, M.
    Mahani, A. Shahidzadeh
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 54 - 54
  • [26] Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin
    Chamilos, G
    Bamias, A
    Efstathiou, E
    Zorzou, PM
    Kastritis, E
    Kostis, E
    Papadimitriou, C
    Dimopoulos, MA
    CANCER, 2005, 103 (12) : 2629 - 2635
  • [27] Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge
    Catherine Sebban
    Sophie Dussart
    Christine Fuhrmann
    Hervé Ghesquieres
    Isabelle Rodrigues
    Lionel Geoffrois
    Yves Devaux
    Laurence Lancry
    Giselle Chvetzoff
    Thomas Bachelot
    Maria Chelghoum
    Pierre Biron
    Supportive Care in Cancer, 2008, 16 : 1017 - 1023
  • [28] What more do you need? Safety of early oral antimicrobials for low-risk neutropenic patients with suspected infection
    Bodilsen, Jacob
    Nielsen, Henrik
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (01) : 15 - 17
  • [29] Oral antibiotics and early hospital discharge for patients with low-risk neutropenic fever with combination: A single-centre experience
    Innes, H
    Ibrahim, A
    Moss, A
    Marshall, E
    BRITISH JOURNAL OF CANCER, 2002, 86 : S70 - S70
  • [30] Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge
    Sebban, Catherine
    Dussart, Sophie
    Fuhrmann, Christine
    Ghesquieres, Herve
    Rodrigues, Isabelle
    Geoffrois, Lionel
    Devaux, Yves
    Lancry, Laurence
    Chvetzoff, Giselle
    Bachelot, Thomas
    Chelghoum, Maria
    Biron, Pierre
    SUPPORTIVE CARE IN CANCER, 2008, 16 (09) : 1017 - 1023
12345